These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 32226530)

  • 1. Copy Number Amplification of DNA Damage Repair Pathways Potentiates Therapeutic Resistance in Cancer.
    Wu Z; Li S; Tang X; Wang Y; Guo W; Cao G; Chen K; Zhang M; Guan M; Yang D
    Theranostics; 2020; 10(9):3939-3951. PubMed ID: 32226530
    [No Abstract]   [Full Text] [Related]  

  • 2. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
    Arjumand W; Asiaf A; Ahmad ST
    Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel DNA damage repair-related gene signature predicting survival, immune infiltration and drug sensitivity in cervical cancer based on single cell sequencing.
    Xiang X; Kang J; Jiang J; Zhang Y; Zhang Y; Li L; Peng X
    Front Immunol; 2023; 14():1198391. PubMed ID: 37449209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer.
    Alkema NG; Tomar T; van der Zee AG; Everts M; Meersma GJ; Hollema H; de Jong S; van Vugt MA; Wisman GB
    Gynecol Oncol; 2014 Jun; 133(3):591-8. PubMed ID: 24657486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of Response and Resistance to DNA Repair Targeted Therapies.
    Stover EH; Konstantinopoulos PA; Matulonis UA; Swisher EM
    Clin Cancer Res; 2016 Dec; 22(23):5651-5660. PubMed ID: 27678458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer.
    Arai H; Elliott A; Xiu J; Wang J; Battaglin F; Kawanishi N; Soni S; Zhang W; Millstein J; Sohal D; Goldberg RM; Hall MJ; Scott AJ; Khushman M; Hwang JJ; Lou E; Weinberg BA; Marshall JL; Lockhart AC; Stafford P; Zhang J; Moretto R; Cremolini C; Korn WM; Lenz HJ
    Clin Cancer Res; 2021 Jun; 27(11):3234-3242. PubMed ID: 33766816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of DNA damage response in chemo- and radio-resistance of cancer cells: Can DDR inhibitors sole the problem?
    Sadoughi F; Mirsafaei L; Dana PM; Hallajzadeh J; Asemi Z; Mansournia MA; Montazer M; Hosseinpour M; Yousefi B
    DNA Repair (Amst); 2021 May; 101():103074. PubMed ID: 33640757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancer.
    Ding K; He Y; Wei J; Fu S; Wang J; Chen Z; Zhang H; Qu Y; Liang K; Gong X; Qiu L; Chen D; Xiao B; Du H
    Front Immunol; 2022; 13():943090. PubMed ID: 36081518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in DNA Damage Repair Genes in Primary Liver Cancer.
    Lin J; Shi J; Guo H; Yang X; Jiang Y; Long J; Bai Y; Wang D; Yang X; Wan X; Zhang L; Pan J; Hu K; Guan M; Huo L; Sang X; Wang K; Zhao H
    Clin Cancer Res; 2019 Aug; 25(15):4701-4711. PubMed ID: 31068370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs.
    Pirlog BO; Ilut S; Pirlog R; Chiroi P; Nutu A; Radutiu DI; Cuc GD; Berindan-Neagoe I; Nabavi SF; Filosa R; Nabavi SM
    Expert Rev Mol Med; 2023 May; 25():e18. PubMed ID: 37154101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Level DNA Damage Repair Pathway Profiles and Anti-Tumor Immunity for Gastric Cancer.
    Lou S; Wang Y; Zhang J; Yin X; Zhang Y; Wang Y; Xue Y
    Front Immunol; 2021; 12():806324. PubMed ID: 35082793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.
    Evans JR; Zhao SG; Chang SL; Tomlins SA; Erho N; Sboner A; Schiewer MJ; Spratt DE; Kothari V; Klein EA; Den RB; Dicker AP; Karnes RJ; Yu X; Nguyen PL; Rubin MA; de Bono J; Knudsen KE; Davicioni E; Feng FY
    JAMA Oncol; 2016 Apr; 2(4):471-80. PubMed ID: 26746117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A20/TNFAIP3 Regulates the DNA Damage Response and Mediates Tumor Cell Resistance to DNA-Damaging Therapy.
    Yang C; Zang W; Tang Z; Ji Y; Xu R; Yang Y; Luo A; Hu B; Zhang Z; Liu Z; Zheng X
    Cancer Res; 2018 Feb; 78(4):1069-1082. PubMed ID: 29233925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage response regulation by microRNAs as a therapeutic target in cancer.
    Majidinia M; Yousefi B
    DNA Repair (Amst); 2016 Nov; 47():1-11. PubMed ID: 27697364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the DNA Damage Response in Cancer.
    O'Connor MJ
    Mol Cell; 2015 Nov; 60(4):547-60. PubMed ID: 26590714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance.
    Esposito MT; So CW
    Chromosoma; 2014 Dec; 123(6):545-61. PubMed ID: 25112726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of DNA Damage Response Genomic Alterations in Relapsed/Advanced Urothelial Cancer.
    Yin M; Grivas P; Wang QE; Mortazavi A; Emamekhoo H; Holder SL; Drabick JJ; Woo MS; Pal S; Vasekar M; Folefac E; Clinton SK; Monk P; Joshi M
    Oncologist; 2020 Aug; 25(8):680-688. PubMed ID: 32275806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor.
    Takagi M; Yoshida M; Nemoto Y; Tamaichi H; Tsuchida R; Seki M; Uryu K; Nishii R; Miyamoto S; Saito M; Hanada R; Kaneko H; Miyano S; Kataoka K; Yoshida K; Ohira M; Hayashi Y; Nakagawara A; Ogawa S; Mizutani S; Takita J
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the microRNA-regulating DNA damage/repair pathways in cancer.
    Bottai G; Pasculli B; Calin GA; Santarpia L
    Expert Opin Biol Ther; 2014 Nov; 14(11):1667-83. PubMed ID: 25190496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage response and prostate cancer: defects, regulation and therapeutic implications.
    Karanika S; Karantanos T; Li L; Corn PG; Thompson TC
    Oncogene; 2015 May; 34(22):2815-22. PubMed ID: 25132269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.